CHPA’s outgoing chair Paul Gama of Procter & Gamble and incoming chair Michelle Goodridge of Johnson & Johnson Consumer Health describe how COVID-19 impacted the consumer healthcare industry.
Lupin received approval for sevelamer hydrochloride tablets, which are indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
According to a study conducted by Pharmavite, 30% of surveyed pharmacists report taking worse care of themselves compared to before the COVID-19 pandemic, due to increasing work commitments.